Steris Plc (STE31) Gross Profit Margin starting from the second quarter 2026 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Steris Plc  (NYSE: STE31)


Steris Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STE31 Gross Profit Margin (Sep 30 2026)
Q2 		(Jun 30 2026)
Q1 		(Dec 31 2022)
Q3 		(Sep 30 2022)
Q2 		(Jun 30 2022)
Q1
Y / Y Revenue Change 51.06 %
Seq. Revenue Change 6.42 %
Revenue In Millions $1,588.60
Gross Profit Margin 44.74 %
Gross Profit Margin Total Ranking # 2016
Gross Profit In Millions $710.80
Y / Y Gross Profit Change 37.27 %
Seq. Gross Profit Change 3.9 %


Commenting Second Quarter 2026 Gross Profit Margin
Steris Plc has managed to improve its Revenue sequentially to $1,588.60 millions by 6.42 % faster than Gross Profit increase of 3.9 % to $710.80 millions, this led to contraction in Gross Profit Margin to 44.74 %, but the Steris Plc II. Quarter Gross Profit Margin remained above company average rate of 43.83%.


Observing second quarter 2026 results within Medical Equipment & Supplies industry 137 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1954 to 2016.
Learn about Gross Margin
STE31's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 389
Overall # 1977

Gross Profit Margin Statistics
High Average Low
49.24 % 43.83 % 40.13 %
(Jun 30 2022)   (Sep 30 2021)


STE31 Gross Income Trends • More of STE31's Profitabilty Ratios • STE31 Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
STE31's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
STE31's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for STE31's Competitors
Gross Profit Margin Profit Margin for Steris Plc's Suppliers
Gross Profit Margin Profit Margin for STE31's Customers

You may also want to know
STE31's Annual Growth Rates STE31's Profitability Ratios STE31's Asset Turnover Ratio STE31's Dividend Growth
STE31's Roe STE31's Valuation Ratios STE31's Financial Strength Ratios STE31's Gross Profit Growth
STE31's Roa STE31's Inventory Turnover Ratio STE31's Growth Rates STE31's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Sanara Medtech Inc   92.60 %$ 26.325  Millions$ 28.430  Millions
Seastar Medical Holding Corp  92.44 %$ 0.587  Millions$ 0.635  Millions
Ceribell Inc   89.77 %$ 26.340  Millions$ 29.341  Millions
Delcath Systems Inc   88.84 %$ 31.184  Millions$ 35.102  Millions
Electrocore Inc   88.47 %$ 8.573  Millions$ 9.690  Millions
Cvrx inc   86.74 %$ 11.998  Millions$ 13.832  Millions
Neuraxis Inc   86.60 %$ 1.756  Millions$ 2.028  Millions
Trisalus Life Sciences Inc   86.15 %$ 11.095  Millions$ 12.878  Millions
Inspire Medical Systems inc   86.05 %$ 177.858  Millions$ 206.695  Millions
Sight Sciences Inc   85.94 %$ 21.420  Millions$ 24.923  Millions
Glaukos Corp  85.23 %$ 179.866  Millions$ 211.030  Millions
Neuropace Inc   84.28 %$ 19.471  Millions$ 23.104  Millions
Avita Medical Inc   84.02 %$ 21.941  Millions$ 26.114  Millions
Heartflow Inc   83.61 %$ 60.917  Millions$ 72.857  Millions
Mobia Medical Inc   83.25 %$ 13.000  Millions$ 15.616  Millions
Solana Company  81.64 %$ 2.743  Millions$ 3.360  Millions
Electromed Inc   79.95 %$ 14.937  Millions$ 18.682  Millions
Mimedx Group Inc   79.80 %$ 49.702  Millions$ 62.283  Millions
Treace Medical Concepts Inc   79.48 %$ 38.350  Millions$ 48.253  Millions
Si bone inc   79.29 %$ 44.167  Millions$ 55.704  Millions
Edwards Lifesciences Corporation  78.48 %$ 1,346.300  Millions$ 1,715.500  Millions
Profound Medical Corp   78.13 %$ 7.680  Millions$ 9.830  Millions
Carlsmed Inc   77.32 %$ 16.665  Millions$ 21.554  Millions
Atricure Inc   77.27 %$ 119.350  Millions$ 154.450  Millions
Sanuwave Health Inc   77.27 %$ 6.629  Millions$ 8.579  Millions
Novocure Limited  76.98 %$ 148.870  Millions$ 193.399  Millions
Tactile Systems Technology Inc   76.74 %$ 70.489  Millions$ 91.858  Millions
Iradimed Corporation  76.26 %$ 18.456  Millions$ 24.203  Millions
Pulmonx Corporation  76.19 %$ 17.399  Millions$ 22.835  Millions
Omada Health Inc   75.88 %$ 69.282  Millions$ 91.306  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.